ATE347597T1 - Apoptin bindendes protein - Google Patents

Apoptin bindendes protein

Info

Publication number
ATE347597T1
ATE347597T1 AT00203042T AT00203042T ATE347597T1 AT E347597 T1 ATE347597 T1 AT E347597T1 AT 00203042 T AT00203042 T AT 00203042T AT 00203042 T AT00203042 T AT 00203042T AT E347597 T1 ATE347597 T1 AT E347597T1
Authority
AT
Austria
Prior art keywords
apoptin
binding protein
novel therapeutic
novel
apoptosis
Prior art date
Application number
AT00203042T
Other languages
English (en)
Inventor
Mathieu Hubertus Mari Noteborn
Oorschot Astrid Adri Danen-Van
Original Assignee
Leadd Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP99202858A external-priority patent/EP1081226A1/de
Priority claimed from EP99203465A external-priority patent/EP1108785A1/de
Application filed by Leadd Bv filed Critical Leadd Bv
Application granted granted Critical
Publication of ATE347597T1 publication Critical patent/ATE347597T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT00203042T 1999-09-02 2000-09-01 Apoptin bindendes protein ATE347597T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99202858A EP1081226A1 (de) 1999-09-02 1999-09-02 Apoptin-bindendes Protein
EP99203465A EP1108785A1 (de) 1999-10-21 1999-10-21 Apoptin-verbundenes Protein

Publications (1)

Publication Number Publication Date
ATE347597T1 true ATE347597T1 (de) 2006-12-15

Family

ID=26153361

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00203042T ATE347597T1 (de) 1999-09-02 2000-09-01 Apoptin bindendes protein

Country Status (20)

Country Link
US (2) US7317096B1 (de)
EP (1) EP1083224B1 (de)
JP (1) JP2003510030A (de)
CN (1) CN100513565C (de)
AT (1) ATE347597T1 (de)
AU (1) AU781127B2 (de)
BR (1) BR0013743A (de)
CA (1) CA2383784A1 (de)
CY (1) CY1106355T1 (de)
DE (1) DE60032201T2 (de)
DK (1) DK1083224T3 (de)
EA (1) EA005933B1 (de)
ES (1) ES2277815T3 (de)
HU (1) HUP0202688A2 (de)
IL (2) IL148469A0 (de)
NO (1) NO20021067L (de)
NZ (1) NZ517740A (de)
PL (1) PL204275B1 (de)
PT (1) PT1083224E (de)
WO (1) WO2001016165A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2393859A1 (en) * 1999-12-10 2001-06-14 Leadd B.V. Apoptin-associating protein
AU2009234253C1 (en) 2008-04-11 2015-05-07 Merrimack Pharmaceuticals, Inc. Human serum albumin linkers and conjugates thereof
WO2011100428A2 (en) * 2010-02-10 2011-08-18 The Uab Research Foundation Compositions for improving bone mass

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9002008A (nl) 1990-09-12 1992-04-01 Stichting Centr Diergeneeskund Recombinant dna en rna en daarvan afgeleide produkten.
EP0878546A1 (de) * 1997-04-15 1998-11-18 Leadd B.V. Genabgabe-Vehikel die das Apoptosis VP2 inducierendes Protein, und/oder Apoptin exprimiert
ATE305514T1 (de) 1994-12-22 2005-10-15 Novartis Pharma Gmbh Nukleäre protein serin/threoninkinasen
NZ309171A (en) * 1995-06-07 2000-04-28 Leadd Bv use of apoptin as an antitumour agent which specifically kills tumour and not normal cells
WO1998039448A2 (en) 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 186 human secreted proteins
WO1999008108A1 (en) * 1997-08-12 1999-02-18 Leadd B.V. Determining the transforming capability of agents
EP0927757A1 (de) * 1997-12-03 1999-07-07 Leadd B.V. Verfahren und Mitteln um Apoptose zu induzieren durch Interferenz mit Bip-ähnliche Proteine
EP0921192A1 (de) 1997-12-03 1999-06-09 Leadd B.V. Molekulen interagierend mit Apoptin
EP0924296A3 (de) * 1997-12-03 2001-08-01 Leadd B.V. Verfahren un Mittteln für die Induktion von Apoptosis durch Interferenz in RNS-Prozessierung
US20030105315A1 (en) 1998-04-09 2003-06-05 Metagen Pharmaceuticals Gmbh Human nucleic acid sequences from ovarian tumor tissue
JP2002513554A (ja) * 1998-05-05 2002-05-14 インサイト・ファーマスーティカルズ・インコーポレイテッド ヒト転写調節分子
CA2393859A1 (en) 1999-12-10 2001-06-14 Leadd B.V. Apoptin-associating protein
EP1106691A1 (de) 1999-12-10 2001-06-13 Leadd B.V. Apoptin verbundenes Protein
EP1111045A3 (de) 1999-12-10 2001-09-19 Leadd B.V. Apoptin-bindendes Protein
JP2003520593A (ja) 2000-01-17 2003-07-08 レアト ベー．フェー． アポプチン会合タンパク質
EP1138765A1 (de) 2000-03-27 2001-10-04 Leadd B.V. Apoptin verbundene Proteine AAP-5 und AAP-6

Also Published As

Publication number Publication date
EA005933B1 (ru) 2005-08-25
EP1083224A3 (de) 2001-04-25
EP1083224A2 (de) 2001-03-14
WO2001016165A3 (en) 2001-09-20
AU781127B2 (en) 2005-05-05
DE60032201T2 (de) 2007-09-20
CA2383784A1 (en) 2001-03-08
IL148469A0 (en) 2002-09-12
NO20021067D0 (no) 2002-03-04
CN100513565C (zh) 2009-07-15
PL204275B1 (pl) 2009-12-31
NO20021067L (no) 2002-05-02
AU7324200A (en) 2001-03-26
WO2001016165A2 (en) 2001-03-08
DE60032201D1 (de) 2007-01-18
US20080176231A1 (en) 2008-07-24
BR0013743A (pt) 2005-01-11
IL148469A (en) 2009-02-11
DK1083224T3 (da) 2007-04-10
CY1106355T1 (el) 2011-10-12
HUP0202688A2 (en) 2002-12-28
NZ517740A (en) 2003-09-26
US7767790B2 (en) 2010-08-03
PT1083224E (pt) 2007-03-30
JP2003510030A (ja) 2003-03-18
EP1083224B1 (de) 2006-12-06
EA200200321A1 (ru) 2002-08-29
PL354285A1 (en) 2003-12-29
US7317096B1 (en) 2008-01-08
CN1387569A (zh) 2002-12-25
ES2277815T3 (es) 2007-08-01

Similar Documents

Publication Publication Date Title
DE60233955D1 (de) Spezifische bindungsmittel von human angiopoietin-2
WO2002057303A3 (en) Protein-protein interactions between shigella flexneri polypeptides and mammalian polypeptides
DE60215848D1 (de) 1,2,4-thiadiazolverbindungen als melanocortinrezeptor-modulatoren
ATE255906T1 (de) Antikörper gegen cd40
SV2003001144A (es) FORMAS CRISTALINAS DE LA SAL DE CALCIO DEL ACIDO [R-(R*,R*)]-2-(4-FLUOROFENIL)-ß,ô-DIHIDROXI-5-(1-METILETIL)-3-FENIL-4[(FENILAMINO)CARBONIL]-1H-PIRROL-1-HEPTANOICO (2:1) REF. PC430-01FJT
DE60103351D1 (de) Zusammensetzung zur Bekämpfung von Ektoparasiten
PL339860A1 (en) Methods of modulating the action of serine/threonine protein kinase by means of compounds based on 5-azaquinoxaline
DK1536778T3 (da) Proteiner, der binder til cross-beta-strukturholdigt amyloid og fremgangsmåder til modulation af cross-beta-strukturen, dens dannelse og dens associerede toksicitet
EA200000519A1 (ru) 2-АРИЛБЕНЗО[b]ТИОФЕНЫ, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ СИНДРОМА ЭСТРОГЕННОЙ НЕДОСТАТОЧНОСТИ
ATE299183T1 (de) Apoptose induzierende proteinesubstanz
ATE347597T1 (de) Apoptin bindendes protein
EA200000520A1 (ru) 2-АРИЛ-3-АРОИЛБЕНЗО[b]ТИОФЕНЫ, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ СИНДРОМА ЭСТРОГЕННОЙ НЕДОСТАТОЧНОСТИ
WO2001072825A3 (en) Apoptin-associating protein
DK1387854T3 (da) SFRP og peptidmotiver som interagerer med SFRP og fremgangsmåder til anvendelse deraf
EA200400392A1 (ru) Связывающий каспазу-8 белок, его получение и применение
DE60038955D1 (de) AN DER OBERFLÄCHE VON KARZINOMZELLEN LOKALISIERTES COLLIGIN/HsP47
WO2001042461A3 (en) Apoptin-associating protein
EP1111045A3 (de) Apoptin-bindendes Protein
WO2001053351A3 (en) Apoptin bindendes protein
EP1138768A3 (de) Apoptin-bindendes Protein AAP-5
EP1118662A3 (de) Apoptin bindendes Protein
WO2003060067A3 (en) P85-alpha nucleic acids, polypeptides and related methods
DK1171470T3 (da) Antistoffer over for placentaprotein 13
WO2002050261A3 (en) PROTEINS THAT INTERACT WITH βTRCP
ATE235509T1 (de) Peptide zur inhibition von hpv e7 proteinen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1083224

Country of ref document: EP

REN Ceased due to non-payment of the annual fee